Adaptive Biotechnologies Overview
Adaptive Biotechnologies Discounted Cash Flow
DCF Analysis for ADPT.
Get informed when a big investor buys or sells
+ FollowFair Value
$3.64
Current Fair Value
$3.64
↓ 79.2% Downside
Overvalued by 79.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison